-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, AML, autoimmune disorders, Biological, Coronaviruses, Follicular Lymphoma, Leukemia, SARS-CoV-2/COVID-19, survivorship, viral, Animal models, CLL, CML, Diseases, Lymphoma (any), Marginal Zone Lymphoma, Bone Marrow Failure, Combinations, Hodgkin Lymphoma, Mantle Cell Lymphoma, Therapies, cellular interactions, MDS, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Biological Processes, DLBCL, immunodeficiency, MPN, white blood cells, immune cells, Immune Disorders, T-Cell Lymphoma, Technology and Procedures, Cell Lineage, immunotherapy, Infectious Diseases, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, Proliferative disorders, Quality Improvement , flow cytometry, immune mechanism, transplantation, inflammation, microenvironment, molecular interactions, pathways
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Jana Ihlow, MD1,2*, Ann-Christin von-Bruenneck, MD1*, Edward Georg Michaelis, MD1*, Selina Greuel, MD1*, Verena Heynol1*, Annika Lehmann, Dr.1*, Helena Radbruch, MD3*, Jenny Meinhardt, MD1*, Victor Max Corman, MD4*, Florian Miller, MD5*, Hermann Herbst, MD, FRCPath5, Jörg Westermann2*, Lars Bullinger, MD6, David Horst, MD1* and Sefer Elezkurtaj, MD1*

1Institute of Pathology, Charite-Universitaetsmedizin Berlin, Berlin, Germany
2Department of Hematology, Oncology and Tumor Immunology, Charite-Universitaetsmedizin Berlin, Berlin, Germany
3Institute of Neuropathology, Charite-Universitaetsmedizin Berlin, 10117, Germany
4Institute of Virology, Charite-Universitaetsmedizin Berlin, Berlin, Germany
5Department of Pathology, Vivantes Netzwerk fuer Gesundheit GmbH, Berlin, Germany
6Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany

Andrea Härzschel1*, Peter William Krenn2*, Elisabeth Bayer3*, Simone Tangermann4*, Geoffroy Andrieux5*, Elif Karabatak1*, Eva Szenes3*, Danielle-Justine Danner1*, Ursula Denk3*, Raphael Ruppert2*, Alexander Egle, MD6, Richard Greil, MD3, Lukas Kenner, MD4*, Melanie Boerries, MD, PhD5* and Tanja Nicole Hartmann, PhD1,3*

1Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany
2Max Planck Institute of Biochemistry, Martinsried, Germany
3Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria
4Unit of laboratory animal pathology, University of Veterinary Medicine Vienna, Vienna, Austria
5Institute of Medical Bioinformatics and Systems Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
6Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria

Elaine Kulm, CRNP-AC1*, Sharon Webster, BSN2*, Kate Howe, PA-C2*, Amy Rump, FNP-BC1*, Gulbu Uzel, MD2* and V. Koneti Rao, MD, FRCPA2

1Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Bethesda, MD
2LCIM DIR, NIAID National Institutes of Health, Bethesda, MD

Augustine Hong, MD1, Augusta Eduafo, DO2*, Hannah Schmikla, RN1*, George Brown3*, Gayathri Ravi, MD4, Marcos de Lima, MD5 and Ehsan Malek, MD6

1University Hospitals Cleveland Medical Center, Cleveland, OH
2Internal Medicine Department, St. John Medical Center, Cleveland, OH
3University Hospitals Cleveland Medical Center, cleveland
4University Hospitals Seidman Cancer Center, Cleveland, OH
5Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
6Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Shaker Hts, OH

George Sakoulas, MD1*, Matthew Geriak, PharmD2*, Ravina Kullar, PharmD2*, Kris Greenwood, PhD2*, MacKenzie Habib2*, Anuja Vyas, MD2*, Mitra Ghafourian, MD2*, Venkata Naga Kiran Dintyala, MD2*, Fadi Haddad, MD2* and Syed Rizvi, PharmD3*

1Sharp Memorial Hospital and the University of San Diego, San Diego, CA
2Sharp Healthcare, San Diego, CA
3Octapharma US, Paramus, NJ

Yvonne Suessmuth, PhD1*, Kayla Betz, BS2*, Alison Yu, PhD3*, Brandi Bratrude4*, Benjamin Watkins, MD5*, Muna Qayed, MD, MSc1, John T. Horan, MD MPH3, Leslie Kean, MD, PhD3 and Amelia Langston, MD6

1Emory University, Atlanta, GA
2Dana-Farber Cancer Institute, Boston Children's Hospital, boston
3Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, MA
4Dana-Farber Cancer Institute, Boston Children's Hospital, Boston
5AFLAC Cancer and Blood Disorders Center, Emory University, Atlanta, GA
6Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA

Leigh Naylor-Adamson1*, Zoe Booth2*, Simon Hart3*, Russell Patmore4, Sujoy Khan5*, David Allsup6* and Monica Arman6*

1Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Owston Ferry, ENG, United Kingdom
2Centre for Atherothrombosis and Metabolic Disease, University of Hull, Hull, ENG, United Kingdom
3Respiratory Research Group, Hull York Medical School, Hull, ENG, United Kingdom
4Department of Haematology, Hull and East Yorkshire Hospitals NHS Trust, Hull, ENG, United Kingdom
5Department of Immunology & Allergy, Hull and East Yorkshire Hospitals NHS Trust, Hull, ENG, United Kingdom
6Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, ENG, United Kingdom

Adi Zoref-Lorenz, MD1,2,3, Jun Murakami, MD/ PHD4*, Liron Hofstetter, MD3,5*, Swaminathan P Iyer, MD6, Ahmad S. Alotaibi, MD7*, Peter Miller, MD, PhD8,9,10*, Elad Guber, MD3,11*, Shiri Weinstein, MD3,12*, Joanne Yacobovich, MD, MPH3,13, Sarah Nikiforow, MD, PhD9, Benjamin L. Ebert, MD, PhD9,10, Oren Pasvolsky, MD3,5*, Pia Raanani, MD3,5, Arnon Nagler, MD3,14, Nancy Berliner, MD15, Naval Daver, MD7, Martin H Ellis2,3* and Michael B. Jordan, MD1,16

1Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Hematology Institute, Meir Medical Center, Kfar Saba, Israel
3Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
4Clinical Laboratory, Transfusion Medicine and cell therapy, University of Toyama, Toyama, Japan
5Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
6Department of Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
7Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
8Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
9Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
10Broad Institute of MIT and Harvard, Cambridge, MA
11The lung institute, Meir Medical Center, Kfar Saba, Israel
12Internal Medicine "D", Sheba Medical Center, Ramat Gan, Israel
13Department of Pediatric Hematology Oncology, Schneider Children's Medical Center, Petach Tikva, Israel
14Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel
15Brigham and Women's Hospital, Boston, MA
16Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

*signifies non-member of ASH